Drug Developer Highland Therapeutics Nabs $6.7M in Financing
Highland Therapeutics Inc., a Toronto-based specialty pharmaceutical company, has secured US$6.7 million in financing. Investors included Highland's clinical development group, which is responsible for the manufacturing and development of the company's two lead compounds. Funding will be used to conduct clinical studies, market research to develop commercialization strategies, and other purposes. Highland Therapeutics is a tenant at innovation hub MaRS Discovery District.
16 August 2013•5 mins read
